Showing results (241-250 of 319) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2022
An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold TumorsJitka Fucikova, Michal Hensler, Lenka Kasikova, et al.
The Lancet. Oncology|March 17, 2022
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trialRebecca Kristeleit, Alla Lisyanskaya, Alexander Fedenko, et al.
Gynecologic Oncology|July 23, 2021
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trialDavid Cibula, Lukas Rob, Peter Mallmann, et al.
The Lancet. Oncology|April 12, 2021
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyRobert L Coleman, Domenica Lorusso, Christine Gennigens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional surveyPatrícia Pinto, Lil Valentin, Martina Borčinová, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2024
Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional surveyPatrícia Pinto, Lil Valentin, Martina Borčinová, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015Andreas du Bois, Alexander Reuss, Eric Pujade-Lauraine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian CancerJoyce F Liu, Isabelle Ray-Coquard, Frederic Selle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2024
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian CancerTereza Lanickova, Michal Hensler, Lenka Kasikova, et al.
Gynecologic Oncology|November 28, 2022
Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN projectLukáš Dostálek, Klára Benešová, Jaroslav Klát, et al.
Pageof 32